Falls and Fractures Among Medicare Beneficiaries Concurrently Receiving Anti-Dementia Drugs and Potentially Risky Medications
Assessment and treatment of symptoms among people with ADRD is complex; concurrent receipt of opioids and dementia medications is uncommon but seems risky. Efforts to eliminate avoidable opioids may decrease adverse events and associated suffering in this population.
Authors
- Deanna Chyn (ORCID: https://orcid.org/0000-0001-7431-2777)
- Ellen R. Meara (ORCID: https://orcid.org/0000-0003-0211-1970)
- Nancy E. Morden
Institutions
- Dartmouth Institute for Health Policy and Clinical Practice (US)
- National Bureau of Economic Research (US)
- Harvard University (US)
Publication Details
- Journal
- Medical Care
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1097/mlr.0000000000002229
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00